GSK using video of Flonase manufacturing in launch of new OTC version

Videos touting manufacturing processes are again being used by a drugmaker to help launch a new product. GlaxoSmithKline's ($GSK) new over-the-counter version of allergy fighter Flonase appeared on retailers' shelves this month, Medical Marketing & Media points out. GSK's promotion includes a Tumblr video in which GSK folk talk about the three-year timeline that was needed to prepare for the launch, as well as how the plant's first robots are able to produce 15,000 bottles in 8-hour shifts. Other videos discuss the unique design of the bottle and other aspects of preparing for the launch. It is the second time recently that manufacturing processes have played a starring role in a drug launch. To help sell its new hemophilia treatment Eloctate, Biogen Idec ($BIIB) released a video via Twitter that explains the manufacturing process. The company said it knew patients were concerned with how their hemophilia treatments were manufactured and chose a video as a way to lay that out. Story | More

Suggested Articles

Cambrex has completed installation of multiple continuous flow reactor platforms at its facility in High Point, North Carolina.

Australia’s Mayne Pharma has opened its $80 million oral solid-dose manufacturing facility in Greenville, North Carolina.

GE is launching its prefab line of drug manufacturing units that will help biopharma companies produce viral vector-based vaccines.